#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLseminars: Tourette syndrome from a computational perspective

Vasco Conceiçao University of Lisbon, Portugal Tourette syndrome (TS) is a neuropsychiatric disorder that is characterized by…

Read More

#IDIBELLseminars: Dynamics of epigenetic heterogeneity during development and ageing

Irene Hernando-Herraez Brabaham Institute, UK One of the most fundamental questions in biology is to understand how…

Read More

#IDIBELLfellows: Virginia Díez-Obrero / Léa Pourchet

The Colon Transcriptome Explorer (CoTrEx): A web resource for exploring BarcUva-Seq data Virginia Díez-Obrero Colorectal Cancer Group…

Read More

#IDIBELLfellows: Carmen Martínez-Fernández / Mercè Cases Escuté

 C. elegans and CRISPR/Cas gene editing to study BAP1 cancer-related mutations and cisplatin chemoresistance Carmen Martínez-Fernández Modeling Human…

Read More

Joint webinar #IDIBELLseminars #IDIBELLequality: Social and mental health impact on women in times of COVID-19

Zulema Altamirano, directora de la Unitat Dona i Ciència de l’Ministeri de Ciència i Innovació. Susana Jiménez,…

Read More

#IDIBELLconnect: Dissecting mechanisms of therapy resistance in lethal prostate cancer

Read More

#IDIBELLconnect: Modeling cellular plasticity to regenerate the intestine

Jordi Guiu Cell Plasticity and Regeneration Group The intestine is the tissue responsible for the digestion and…

Read More

#IDIBELLconnect: The TGF-β pathway: A pharmacological target in hepatocellular carcinoma?

Isabel Fabregat TGF-beta and cancer Group Pathways involved both in immunosuppression and cancer development and progression represent…

Read More

Webinar IRISCAT-Dr. Rafael Máñez “Generació d’immunitat protectora contra les infeccions”

Rafael Máñez Mendiluce Innate Immunity and Pathology of the Critical patient Group Els anticossos són un dels…

Read More

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Protein synthesis is the final step of the central dogma of biology that converts the genetic information…

Read More
Scroll to Top